Adialante
PrivateLast Round
Seed
Jul 1, 2026
Total Funding Raised
$3.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Adialante is a medical device company that develops affordable, compact, and mobile MRI systems designed to make cancer screening more accessible.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adialante Comparables
Compare Adialante with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepSpin | 80% | |
| PhysioMRI Tech S.L. | 77% | |
| Promaxo | 77% | |
Adialante Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2026 | ||||
| Accelerator | Apr 23, 2026 | ||||
| Grant | Jun 19, 2025 | ||||
| Seed | Aug 30, 2024 | ||||
| Grant | Jun 30, 2024 | ||||
Grant | Dec 1, 2023 |
Key People
Founding team and executive leadership
Adialante Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Accelerator |
| Walleye Tank | Grant |
| America's Seed Fund | Grant |
| Y Combinator | Accelerator |
| University of Minnesota | Seed, Grant |
| Fogarty Innovation | Seed, Accelerator |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 3, 43% of headcount.
- Aug 10, 2026
Open roles increased to 2, 29% of headcount.
Adialante Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adialante's valuation, stock price, and market status.